For: | Vitale A, Volk M, Cillo U. Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol 2013; 19(48): 9183-9188 [PMID: 24409046 DOI: 10.3748/wjg.v19.i48.9183] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9183.htm |
Number | Citing Articles |
1 |
Alessandro Vitale, Federica Scolari, Alessandra Bertacco, Enrico Gringeri, Francesco D’Amico, Domenico Bassi, Francesco Enrico D’Amico, Paolo Angeli, Patrizia Burra, Quirino Lai, Umberto Cillo. Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?. Cancers 2021; 13(10): 2406 doi: 10.3390/cancers13102406
|
2 |
Vincenzo Mazzaferro, Piergiorgio Danelli, Guido Torzilli, Michele Droz dit Busset, Matteo Virdis, Carlo Sposito. A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic. Annals of Surgery 2020; 272(2): e84 doi: 10.1097/SLA.0000000000004005
|
3 |
Quirino Lai, Alessandro Vitale, Samuele Iesari, Armin Finkenstedt, Gianluca Mennini, Gabriele Spoletini, Maria Hoppe‐Lotichius, Giovanni Vennarecci, Tommaso M. Manzia, Daniele Nicolini, Alfonso W. Avolio, Anna Chiara Frigo, Ivo Graziadei, Massimo Rossi, Emmanouil Tsochatzis, Gerd Otto, Giuseppe M. Ettorre, Giuseppe Tisone, Marco Vivarelli, Salvatore Agnes, Umberto Cillo, Jan Lerut. Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer. Hepatology 2017; 66(6): 1910 doi: 10.1002/hep.29342
|
4 |
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
|
5 |
Morten Hagness. Liver transplantation in treatment of colorectal liver metastases. Hepatic Oncology 2015; 2(2): 181 doi: 10.2217/hep.15.3
|
6 |
Edoardo G. Giannini, Giulia Pieri, Sara Labanca, Maria Corina Plaz Torres, Antonio Gasbarrini, Elisabetta Biasini, Claudia Campani, Nora Cazzagon, Francesco Giuseppe Foschi, Andrea Mega, Alberto Masotto, Giovanni Raimondo, Gian Ludovico Rapaccini, Rodolfo Sacco, Eugenio Caturelli, Maria Guarino, Francesco Tovoli, Gianpaolo Vidili, Maurizia Rossana Brunetto, Gerardo Nardone, Gianluca Svegliati-Baroni, Donatella Magalotti, Francesco Azzaroli, Giuseppe Cabibbo, Maria Di Marco, Angelo Sangiovanni, Franco Trevisani, Maurizio Biselli, Paolo Caraceni, Annagiulia Gramenzi, Francesca Benevento, Alessandro Granito, Luca Muratori, Fabio Piscaglia, Federica Bertellini, Fabio Farinati, Giorgio Palano, Filippo Pelizzaro, Barbara Penzo, Elisa Pinto, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Caterina Stornello, Mauro Grova, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Andrea Casadei Gardini, Fabio Conti, Lucia Napoli, Marco Domenicali, Maria Teresa Migliano, Nicoletta de Matthaeis, Francesca Romana Ponziani, Andrea Olivani, Gabriele Missale, Valentina Cossiga, Mario Capasso, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgia Ghittoni, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Maria Stella Franzè, Carlo Saitta, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Rita Golfieri, Cristina Mosconi, Matteo Renzulli. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. Digestive and Liver Disease 2022; 54(9): 1215 doi: 10.1016/j.dld.2022.03.002
|
7 |
Giovanni Guaraldi, Giovanni Dolci, Stefano Zona, Giuseppe Tarantino, Valentina Serra, Roberto Ballarin, Erica Franceschini, Mauro Codeluppi, Thomas D. Brothers, Cristina Mussini, Fabrizio Di Benedetto. A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients. AIDS Research and Therapy 2017; 14(1) doi: 10.1186/s12981-017-0163-x
|
8 |
Utz Settmacher, Aladdin Ali-Deeb, Laurent Coubeau, Umberto Cillo, Pål-Dag Line, Markus Guba, Silvio Nadalin, Falk Rauchfuß. Auxilliary Liver Transplantation According to the RAPID Procedure in Noncirrhotic Patients. Annals of Surgery 2023; 277(2): 305 doi: 10.1097/SLA.0000000000005726
|
9 |
Enrico Gringeri, Alessandro Furlanetto, Jacopo Lanari, Andrea Marchini, Annalisa Dolcet, Domenico Bassi, Riccardo Boetto, Francesco Enrico D’Amico, Alessandra Bertacco, Luca Perin, Eleonora Nieddu, Mattia Ballo, Eugenia Rosso, Clarissa De Nardi, Nicola Canitano, Umberto Cillo. LIVING DONOR LIVER DONATION IN THE ONCOLOGICAL FIELD: WHAT’S NEW. European Journal of Transplantation 2024; 2(1): 22 doi: 10.57603/EJT-434
|
10 |
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. Medical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
|
11 |
Prashant Bhangui, Sanjiv Saigal, Dheeraj Gautam, Tarun Piplani, Narendra Choudhary, Rohan Chaudhary, Sanjay Yadav, S. Thiagarajan, Amit Rastogi, Neeraj Saraf, Samiran Nundy, A.S. Soin. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria. Liver Transplantation 2021; 27(2): 209 doi: 10.1002/lt.25956
|
12 |
Stefano Di Sandro, Leonardo Centonze, Barbara Catellani, Roberta Odorizzi, Daniela Caracciolo, Cristiano Guidetti, Paolo Magistri, Giuseppe Esposito, Gian Piero Guerrini, Fabrizio Di Benedetto. Current role and perspectives of living donor liver transplantation for hepatocellular carcinoma: systematic review of the past 20 years. Updates in Surgery 2024; doi: 10.1007/s13304-024-01862-y
|
13 |
Neil Mehta, Prashant Bhangui, Francis Y. Yao, Vincenzo Mazzaferro, Christian Toso, Nobuhisa Akamatsu, Francois Durand, Jan Ijzermans, Wojciech Polak, Shusen Zheng, John P. Roberts, Gonzalo Sapisochin, Taizo Hibi, Nancy Man Kwan, Mark Ghobrial, Avi Soin. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation 2020; 104(6): 1136 doi: 10.1097/TP.0000000000003174
|
14 |
Sarah R. Kaslow, Alejandro Torres-Hernandez, Feng Su, AnnMarie Liapakis, Adam Griesemer, Karim J. Halazun. Survival benefit of living donor liver transplant for patients with hepatocellular carcinoma. Updates in Surgery 2024; doi: 10.1007/s13304-024-01947-8
|
15 |
Vincenzo Mazzaferro, Riccardo Lencioni, Pietro Majno. Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation. Seminars in Liver Disease 2014; 34(04): 415 doi: 10.1055/s-0034-1394365
|
16 |
Umberto Cillo, Alessandro Vitale, Michael L. Volk, Anna Chiara Frigo, Paolo Feltracco, Annamaria Cattelan, Giuseppina Brancaccio, Giuseppe Feltrin, Paolo Angeli, Patrizia Burra, Sara Lonardi, Silvia Trapani, Massimo Cardillo. Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources. Cancers 2021; 13(6): 1416 doi: 10.3390/cancers13061416
|
17 |
Eliza W. Beal, Clifford Akateh, Dmitry Tumin, Fabio Bagante, Sylvester M. Black, Kenneth Washburn, Daniel Azouley, Timothy M. Pawlik. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score. Experimental and Clinical Transplantation 2020; 18(4): 491 doi: 10.6002/ect.2018.0346
|
18 |
Alessandro Vitale, Markus Peck-Radosavljevic, Edoardo G. Giannini, Eric Vibert, Wolfgang Sieghart, Sven Van Poucke, Timothy M. Pawlik. Personalized treatment of patients with very early hepatocellular carcinoma. Journal of Hepatology 2017; 66(2): 412 doi: 10.1016/j.jhep.2016.09.012
|
19 |
Marcello Di Martino, Alessandro Vitale, Daniele Ferraro, Marilisa Maniscalco, Donatella Pisaniello, Giuseppe Arenga, Federica Falaschi, Alfonso Terrone, Alessandro Iacomino, Alfonso Galeota Lanza, Ciro Esposito, Umberto Cillo, Giovanni Vennarecci. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes. Cancers 2022; 14(20): 5102 doi: 10.3390/cancers14205102
|
20 |
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review). Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
|
21 |
Giuseppe Cabibbo, Bruno Daniele, Mauro Borzio, Andrea Casadei-Gardini, Umberto Cillo, Agostino Colli, Massimiliano Conforti, Vincenzo Dadduzio, Francesco Dionisi, Fabio Farinati, Ivan Gardini, Edoardo Giovanni Giannini, Rita Golfieri, Maria Guido, Andrea Mega, Silvia Minozzi, Fabio Piscaglia, Lorenza Rimassa, Laura Romanini, Anna Pecorelli, Rodolfo Sacco, Marta Scorsetti, Luca Viganò, Alessandro Vitale, Franco Trevisani. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments. Digestive and Liver Disease 2024; 56(2): 223 doi: 10.1016/j.dld.2023.10.029
|
22 |
Keyur Patel, Ryan Lamm, Peter Altshuler, Hien Dang, Ashesh P. Shah. Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy. International Journal of Molecular Sciences 2020; 21(18): 6757 doi: 10.3390/ijms21186757
|
23 |
Arvinder Soin, Mickaël Lesurtel, Prashant Bhangui, Lorenzo Cocchi, Mohamed Bouattour, Pierre-Alain Clavien. Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?. Journal of Hepatology 2023; 78(6): 1124 doi: 10.1016/j.jhep.2023.03.032
|
24 |
Prashant Bhangui. Liver transplantation and portal vein tumour thrombus: futile enterprise?. Current Opinion in Organ Transplantation 2022; 27(4): 312 doi: 10.1097/MOT.0000000000000997
|
25 |
Michael Mohnasky, Sandra Gad, Andrew Moon, A. Sidney Barritt, Resmi A. Charalel, Caroline Eckblad, Andrew Caddell, Minzhi Xing, Nima Kokabi. Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions. Journal of the American College of Radiology 2025; 22(3): 260 doi: 10.1016/j.jacr.2024.10.014
|
26 |
Marianna Maspero, Carlo Sposito, Matteo Virdis, Davide Citterio, Filippo Pietrantonio, Sherrie Bhoori, Filiberto Belli, Vincenzo Mazzaferro. Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues. Cancers 2023; 15(2): 345 doi: 10.3390/cancers15020345
|
27 |
|
28 |
Umberto Cillo, Enrico Gringeri, Francesco Enrico D'Amico, Jacopo Lanari, Alessandro Furlanetto, Alessandro Vitale. Hepatocellular carcinoma: Revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy. Digestive and Liver Disease 2025; 57(4): 809 doi: 10.1016/j.dld.2024.12.003
|
29 |
Bruno Sangro, Josepmaria Argemi, Maxime Ronot, Valerie Paradis, Tim Meyer, Vincenzo Mazzaferro, Peter Jepsen, Rita Golfieri, Peter Galle, Laura Dawson, Maria Reig. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. Journal of Hepatology 2025; 82(2): 315 doi: 10.1016/j.jhep.2024.08.028
|
30 |
JI QIN GAI, XIA SHENG, JIAN MIN QIN, KANG SUN, WEI ZHAO, LEI NI. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway. International Journal of Oncology 2016; 48(1): 338 doi: 10.3892/ijo.2015.3250
|
31 |
Ji-Hye Kwon, Sangbin Han, Doyeon Kim, Joon Hee Kuk, Hyun Cho, Seonwoo Kim, Ju Dong Yang, Chul Kim, Jong Man Kim, Gyu Sung Choi, Jae-Won Joh, Justin S. Ko, Mi Sook Gwak, Gaabsoo Kim. Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma. Annals of Surgery 2022; 276(6): e842 doi: 10.1097/SLA.0000000000004866
|
32 |
Umberto Cillo, Alessandro Furlanetto, Enrico Gringeri, Alessandra Bertacco, Andrea Marchini, Eugenia Rosso, Domenico Bassi, Francesco Enrico D’Amico, Pal Dag Line. Advocating for a “shift-to-left” in transplant oncology: left grafts, RAPID and dual graft. Updates in Surgery 2024; doi: 10.1007/s13304-024-01919-y
|
33 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
|
34 |
Prashant Bhangui. Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?. Hepatobiliary & Pancreatic Diseases International 2024; 23(2): 123 doi: 10.1016/j.hbpd.2023.10.002
|